Literature DB >> 27125634

Parkinson disease: Insect screens for PD therapies - keep the flies in.

Ian Martin1, Vinita G Chittoor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27125634     DOI： 10.1038/nrneurol.2016.56

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

Authors:  Xuemei Huang; Alvaro Alonso; Xuguang Guo; David M Umbach; Maya L Lichtenstein; Christie M Ballantyne; Richard B Mailman; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2015-01-14       Impact factor: 10.338

2.  Kinase activity of mutant LRRK2 mediates neuronal toxicity.

Authors:  Wanli W Smith; Zhong Pei; Haibing Jiang; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  Nat Neurosci       Date:  2006-09-17       Impact factor: 24.884

3.  LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.

Authors:  Chin-Hsien Lin; Pei-I Tsai; Ruey-Meei Wu; Cheng-Ting Chien
Journal:  J Neurosci       Date:  2010-09-29       Impact factor: 6.167

4.  Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

Authors:  Andrew B West; Darren J Moore; Saskia Biskup; Artem Bugayenko; Wanli W Smith; Christopher A Ross; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-03       Impact factor: 11.205

Review 5.  Drosophila models of Parkinson's disease.

Authors:  Alexander J Whitworth
Journal:  Adv Genet       Date:  2011       Impact factor: 1.944

6.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Authors:  Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

7.  Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.

Authors:  Chin-Hsien Lin; Han-I Lin; Meng-Ling Chen; Tzu-Ting Lai; Li-Ping Cao; Matthew J Farrer; Ruey-Meei Wu; Cheng-Ting Chien
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

Review 8.  Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinic.

Authors:  Andrew B West
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

9.  Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2.

Authors:  Dario C Angeles; Patrick Ho; Brian W Dymock; Kah-Leong Lim; Zhi-Dong Zhou; Eng-King Tan
Journal:  Ann Clin Transl Neurol       Date:  2016-03-02       Impact factor: 4.511

10.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.